Skip to main content

Animations

MJFF Publications

5081 - 5090 of 8823 Results
Title
Year
  • Year
  • 2015
  • 2021
  • 2021
  • 2022
  • 2024
  • 2021
  • 2023
  • 2023
  • 2024
  • 2012
  • Summary Details
    OPEN
    Title: Large-scale assessment of polyglutamine repeat expansions in Parkinson disease
    Journal Name: Neurology
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1212/wnl.0000000000002016
    Citation Count: 31
  • Summary Details
    OPEN
    Title: Sphingolipid changes in Parkinson L444P GBA mutation fibroblasts promote α-synuclein aggregation
    Journal Name: Brain
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc, cc-by-nc
    DOI - Digital Object Identifier: 10.1093/brain/awab371
    Citation Count: 77
  • Summary Details
    OPEN
    Title: Diagnostic value of cerebrospinal fluid alpha-synuclein seed quantification in synucleinopathies
    Journal Name: Brain
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc, cc-by-nc
    DOI - Digital Object Identifier: 10.1093/brain/awab431
    Citation Count: 178
  • Summary Details
    OPEN
    Title: The GBA variant E326K is associated with alpha-synuclein aggregation and lipid droplet accumulation in human cell lines
    Journal Name: Human Molecular Genetics
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1093/hmg/ddac233
    Citation Count: 13
  • Summary Details
    OPEN
    Title: Neuroanatomical Signature of the Transition from Normal Cognition to MCI in Parkinson's Disease
    Journal Name: Aging and disease
    Publisher: Aging and Disease
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.14336/ad.2024.0323
    Citation Count: 7
  • Summary Details
    OPEN
    Title: Dystonia Responsive to Dopamine: POLG Mutations Should Be Considered If Sensory Neuropathy Is Present
    Journal Name: Journal of Movement Disorders
    Publisher: The Korean Movement Disorder Society
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc, cc-by-nc
    DOI - Digital Object Identifier: 10.14802/jmd.20159
    Citation Count: 10
  • Summary Details
    OPEN
    Title: A blood-based marker of mitochondrial DNA damage in Parkinson’s disease
    Journal Name: Science Translational Medicine
    Publisher: American Association for the Advancement of Science (AAAS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1126/scitranslmed.abo1557
    Citation Count: 76
  • Summary Details
    RESTRICTED
    Title: Shifting the trajectory of therapeutic development for neurological and psychiatric disorders
    Journal Name: Science Translational Medicine
    Publisher: American Association for the Advancement of Science (AAAS)
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1126/scitranslmed.adg4775
    Citation Count: 9
  • Summary Details
    OPEN
    Title: Parkinson’s disease psychosis associated with accelerated multidomain cognitive decline
    Journal Name: BMJ Mental Health
    Publisher: BMJ
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1136/bmjment-2024-301062
    Citation Count: 15
  • Summary Details
    OPEN
    Title: GBA mutations increase risk for Lewy body disease with and without Alzheimer disease pathology
    Journal Name: Neurology
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1212/wnl.0b013e3182735e9a
    Citation Count: 155
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.